TLX News: FDA Approves New Prostate Cancer Imaging Agent Gozellix® - 21st Mar 2025, 9:30pm

annb0t

Top 20
Telix Pharmaceuticals Limited

MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Gozellix® (TLX007-CDx, kit for the preparation of gallium-68 (68Ga) gozetotide injection), Telix’s next-generation PSMA-PET imaging1 agent for prostate cancer.

Gozellix®, after rad...

>>> Read more: FDA Approves New Prostate Cancer Imaging Agent Gozellix®
 
Top Bottom